Moderna's unexpected patent infringement lawsuit against Pfizer and BioNTech over COVID vaccine technology says more about the future market for mRNA shots than the current state of the pandemic.
The big picture: With the federal government's vaccine purchases likely to drop off, experts see top manufacturers jockeying for customers and using the technology for other conditions.